美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

美國抗疫概念

1,362.06

-2.5455-0.19%

漲家數：5

跌家數：14

平家數：1

市盈率：- -

高：1,380.29

開：1,364.76

低：1,361.55

收：1,364.65

資料載入中...

阿斯利康涉嫌未繳納進口税，在華或面臨800萬美元新罰款，一季度中國市場業績增長小於整體新興市場

減肥藥“斷腕”、核心藥物承壓輝瑞（PFE.US）欲“買買買”加碼心臟代謝短板

減肥藥“斷腕”、核心藥物承壓輝瑞欲“買買買”加碼心臟代謝短板

【洞察】達格列淨二甲雙胍緩釋片屬於口服降糖複方製劑我國市場競爭在不斷加劇

Ofweek维科网

阿斯利康中國區一季度收入增5% 或面臨最高800萬美元新罰單

阿斯利康公佈中國調查最新進展

阿斯利康回應在中國面臨最新罰款

阿斯利康再披露中國區涉嫌走私及侵犯公民信息案件進展

輝瑞4月29日成交額為23.31億美元

21健訊Daily | 接棒吳以芳，陳玉卿出任復星醫藥董事長；阿斯利康一季度收入135.88億美元

21世纪经济报道

阿斯利康在華面臨800萬美元新罰款？公司回應了

21世纪经济报道

阿斯利康4月29日成交額為5.64億美元

雅培4月29日成交額為5.63億美元

【吉利德科學與美國政府達成2億美元和解協議】吉利德科學與美國政府達成2.02億美元的和解協議，以解決其向醫生支付費用併為他們提供活動餐費和差旅費以讓其開出其藥物的指控。曼哈頓聯邦檢察官指控，吉利德從2011年1月至2017年11月實施部分計劃，以推廣和增加其治療艾滋病毒的藥物的銷售量。該等活動原本純粹是為了教育目的，並提供簡單的餐點，但該公司在高檔餐廳舉辦活動。檢察官稱，許多醫生隨後開出該公司的藥物，迫使聯邦醫療保健計劃為該等處方支付數百萬美元的報銷費用。

阿斯利康在中國或面臨800萬美元新罰款，涉及乳腺癌藥物

多款 FIC 生物新藥首發 AACR ！來自阿斯利康、GSK、信達...

Insight数据库

阿斯利康在中國或面臨800萬美元新罰款，涉及乳腺癌藥物

吉利德科學公司在美國就艾滋病藥物回扣問題達成和解，將支付 2.02 億美元

阿斯利康盤中異動下午盤股價大漲3.02%報72.05美元

吉利德科學公司就醫生回扣問題與美國達成 2.02 億美元和解協議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1362.0999,"timestamp":1746021106430,"preClose":1364.6454,"halted":0,"volume":14782795,"delay":0,"changeRate":-0.001865,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-2.545532,"latestTime":"04-30 09:51:46 EDT","open":1364.7573,"high":1380.285,"low":1361.5524,"amount":640183451.078521,"amplitude":0.013727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.640146,"peRate":22.008402,"turnoverRate":0.000953,"increases":5,"decrements":14,"flats":1,"marketCap":1124889924930,"floatMarketCap":1105210586760.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1380.285,"amplitude":0.013727,"preClose":1364.6454,"low":1361.5524,"pbRate":"3.640146","latestPrice":1362.0596,"volume":14786065,"delay":0,"open":1364.7573,"prevYearClose":1274.8187,"prevWeekClose":1341.1263,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1344.1606,"twentyDayClose":1377.6108,"sixtyDayClose":1350.7439,"secType":"PLATE","market":"US","turnoverRate":0.000953,"peRate":22.008402,"marketCap":1124889924930,"floatMarketCap":1105210586760.5,"timestamp":1746021107491,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":14,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531703130","title":"阿斯利康涉嫌未繳納進口税，在華或面臨800萬美元新罰款，一季度中國市場業績增長小於整體新興市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2531703130","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531703130?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 15:24","pubTimestamp":1745997883,"startTime":"0","endTime":"0","summary":"蓝鲸新闻4月30日讯 阿斯利康可能会在中国面临一项新的罚款，金额或达800万美元。英国当地时间4月29日，阿斯利康公布2025年一季报，其中单独对中国市场“2025年4月，与中国调查有关的事态发展”做出了详细描述。意见书显示阿斯利康涉嫌偷逃进口税款，金额达160余万美元。若阿斯利康被最终判定需承担法律责任，可能被处以未缴进口税款一至五倍的罚金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/256427","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU1829250122.USD","LU0109394709.USD","LU0320765992.SGD","BK4568","BK4614","LU0889565916.HKD","BK4007","LU2236285917.USD","AZN","LU2462157665.USD","LU2417539215.USD","YINN","BK4585","BK4588","LU2456880835.USD"],"gpt_icon":0},{"id":"2531774147","title":"減肥藥“斷腕”、核心藥物承壓  輝瑞（PFE.US）欲“買買買”加碼心臟代謝短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531774147?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 14:57","pubTimestamp":1745996275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞在2025年第一季度财报中披露，继口服减肥药Danuglipron研发受挫后，公司将通过收购或合作加速布局心脏代谢领域，以弥补产品线空缺。为应对业绩波动，辉瑞升级成本管控计划：在2025年底前实现45亿美元净成本节约的基础上，进一步追加12亿美元节省目标，预计到2027年底累计节省57亿美元。据了解，4月中旬，辉瑞宣布终止GLP-1受体激动剂Danuglipron的研发。辉瑞正面临核心管线断档与成本压力的双重挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002270589.USD","LU0225284248.USD","SG9999002224.SGD","SG9999002232.USD","SG9999003800.SGD","LU0122379950.USD","LU1894683348.USD","BK4581","LU0225771236.USD","IE00B19Z3581.USD","BK4592","BK4550","LU0868494617.USD","BK4588","LU0058720904.USD","LU1057294990.SGD","IE00BLSP4452.SGD","SG9999001176.USD","BK4533","SG9999001176.SGD","LU1066051498.USD","LU0306807586.USD","PFE","IE000M9KFDE8.USD","LU0985481810.HKD","LU0289739699.SGD","LU0456855351.SGD","LU0234572021.USD","SG9999013999.USD","LU0170899867.USD","LU0321505439.SGD","LU1066053197.SGD","SG9999011175.SGD","BK4007","LU1894683264.USD","BK4568","BK4599","SGXZ57979304.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0306806265.USD","LU1883839398.USD","BK4534","BK4585"],"gpt_icon":1},{"id":"2531312703","title":"減肥藥“斷腕”、核心藥物承壓輝瑞欲“買買買”加碼心臟代謝短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531312703","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531312703?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 14:57","pubTimestamp":1745996220,"startTime":"0","endTime":"0","summary":"辉瑞在2025年第一季度财报中披露，由于口服减肥药Danuglipron研发受挫，公司将通过收购或合作加速布局心脏代谢领域，以弥补产品线空缺。尽管Q1营收未达预期，但调整后每股收益超预期，公司维持全年盈利指引上限。新冠产品表现不一，Paxlovid收入低于预期，而Comirnaty疫苗超出预期。核心药物如Eliquis销售额下滑。为应对业绩波动，辉瑞升级成本管控计划，预计到2027年底累计节省57亿美元。辉瑞CEO表示将通过内部研发和外部合作构建心脏代谢领域产品矩阵。分析师认为，通过收购或合作快速补充产品线是突破增长瓶颈的关键。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430150811974b363e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430150811974b363e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306806265.USD","IE0002270589.USD","IE000M9KFDE8.USD","BK4533","LU0456855351.SGD","LU1066051498.USD","BK4581","LU1023059063.AUD","IE00BLSP4452.SGD","LU0321505868.SGD","BK4007","IE00BBT3K403.USD","LU1057294990.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","IE00B19Z3581.USD","LU0225771236.USD","BK4585","SG9999013999.USD","LU0868494617.USD","BK4588","LU1894683348.USD","LU1894683264.USD","PFE","SG9999002224.SGD","BK4534","BK4568","IE00BLSP4239.USD","LU0225284248.USD","LU1883839398.USD","BK4599","LU0985481810.HKD","SG9999003800.SGD","LU0170899867.USD","SG9999011175.SGD","LU0234572021.USD","BK4592","LU0058720904.USD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU0122379950.USD","SG9999001176.USD","LU0306807586.USD","SG9999001176.SGD"],"gpt_icon":0},{"id":"2531770654","title":"【洞察】達格列淨二甲雙胍緩釋片屬於口服降糖複方製劑 我國市場競爭在不斷加劇","url":"https://stock-news.laohu8.com/highlight/detail?id=2531770654","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531770654?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 14:22","pubTimestamp":1745994136,"startTime":"0","endTime":"0","summary":"达格列净二甲双胍缓释片是一种新型口服降糖复方制剂，结合了达格列净及盐酸二甲双胍缓释片两种药物作用机制。达格列净二甲双胍缓释片适用于2型糖尿病的治疗。复方制剂是口服降糖药市场新风口，近年来，我国市场规模逐年增长，达格列净二甲双胍缓释片作为新型口服降糖复方制剂，市场发展前景好。目前达格列净二甲双胍缓释片市场已吸引一大批企业布局，未来国产仿制药将逐渐侵蚀进口原研药市场份额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430142221974b299c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430142221974b299c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AZN","BK4585","LU2462157665.USD","LU1829250122.USD","BK4007","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU2417539215.USD","LU2236285917.USD","LU0109394709.USD","LU2456880835.USD","BK4568"],"gpt_icon":0},{"id":"2531550777","title":"阿斯利康中國區一季度收入增5% 或面臨最高800萬美元新罰單","url":"https://stock-news.laohu8.com/highlight/detail?id=2531550777","media":"澎湃新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531550777?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 14:18","pubTimestamp":1745993893,"startTime":"0","endTime":"0","summary":"【阿斯利康中国区一季度收入增5% 或面临最高800万美元新罚单】当地时间4月29日，跨国药企阿斯利康在公布2025年一季报的同时，再次披露了阿斯利康中国调查事件截至2025年4月的新进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504303394375729.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504303394375729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0109394709.USD","LU2456880835.USD","BK4588","LU0320765992.SGD","BK4585","LU1829250122.USD","LU2417539215.USD","BK4568","BK4007","LU2236285917.USD","LU2462157665.USD","AZN","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531776468","title":"阿斯利康公佈中國調查最新進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2531776468","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531776468?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 13:16","pubTimestamp":1745990160,"startTime":"0","endTime":"0","summary":"4月30日，阿斯利康向第一财经记者透露了该公司在中国接受调查的最新进展。“关于涉嫌侵犯公民个人信息一事，阿斯利康收到了来自深圳市公安局宝安分局出具的有关涉嫌侵犯公民个人信息的《案件移送审查起诉告知书》。公司得悉，就该等侵犯公民个人信息行为，公司无违法所得。”阿斯利康还称，将继续全力配合中国相关部门。（第一财经记者 钱童心）\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-04-30/doc-ineuxmqz4321629.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-30/doc-ineuxmqz4321629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0320765992.SGD","BK4588","AZN","LU2417539215.USD","LU2462157665.USD","LU0889565916.HKD","LU0109394709.USD","LU1829250122.USD","LU2456880835.USD","BK4568","LU2236285917.USD","BK4585","BK4007"],"gpt_icon":0},{"id":"2531778845","title":"阿斯利康回應在中國面臨最新罰款","url":"https://stock-news.laohu8.com/highlight/detail?id=2531778845","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531778845?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 12:59","pubTimestamp":1745989179,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["AZN","LU1829250122.USD","LU2417539215.USD","LU0320765992.SGD","BK4568","LU0109394709.USD","LU2456880835.USD","LU2462157665.USD","BK4585","BK4007","LU2236285917.USD","BK4588","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531721225","title":"阿斯利康再披露中國區涉嫌走私及侵犯公民信息案件進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2531721225","media":"界面","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531721225?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 11:37","pubTimestamp":1745984220,"startTime":"0","endTime":"0","summary":"前述文件显示，阿斯利康涉嫌偷逃进口税款，金额达160余万美元。阿斯利康称，将继续全力配合中国相关部门。这是阿斯利康今年第二次发布阿斯利康中国的调查进展。今年2月初，阿斯利康在公布企业2024年度财报的同时，也对涉嫌非法进口药品一事首度作出了回应。截至目前，对于涉嫌非法进口药品以及涉嫌侵犯公民个人信息事件是否与阿斯利康全球执行副总裁、国际业务主席及中国总裁王磊被调查拘留的动态相关，阿斯利康方面依旧未直接说明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430113748a46d1695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430113748a46d1695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU2456880835.USD","BK4588","LU0320765992.SGD","BK4585","LU1829250122.USD","LU2417539215.USD","BK4568","BK4007","LU2236285917.USD","LU2462157665.USD","AZN","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531723794","title":"輝瑞4月29日成交額為23.31億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531723794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531723794?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 10:21","pubTimestamp":1745979667,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，辉瑞成交额为23.31亿美元，成交额较昨日增加80.85%，当日成交量为9854.02万股。辉瑞于2025年4月29日涨3.21%，报23.79美元，该股过去5个交易日涨5.59%，年初至今跌8.84%，过去60日跌10.29%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|23.31亿|80.85%|9854.02万|#|2025-04-28|12.89亿|57.16%|5588.89万|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102116a46d0133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102116a46d0133&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU0985481810.HKD","LU1066053197.SGD","BK4588","IE00BLSP4452.SGD","LU0456855351.SGD","LU0321505439.SGD","LU0289739699.SGD","PFE","LU0868494617.USD","SG9999001176.USD","BK4599","LU1883839398.USD","IE0002270589.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU1894683264.USD","BK4585","LU0122379950.USD","BK4550","BK4581","LU0058720904.USD","LU0306806265.USD","LU0306807586.USD","SG9999001176.SGD","LU0321505868.SGD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4534","SG9999003800.SGD","LU0234572021.USD","LU0170899867.USD","LU1894683348.USD","SG9999002224.SGD","LU1057294990.SGD","BK4592","LU1066051498.USD","BK4007","SG9999002232.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4568","SG9999011175.SGD","LU0225284248.USD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2531747910","title":"21健訊Daily | 接棒吳以芳，陳玉卿出任復星醫藥董事長；阿斯利康一季度收入135.88億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531747910","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531747910?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 09:33","pubTimestamp":1745976806,"startTime":"0","endTime":"0","summary":"政策动向海南：促进仿制药质量提升支持首仿品种加快注册上市4月29日，《海南省全面深化药品医疗器械化妆品监管改革促进医药产业高质量发展实施方案》对外发布。其中提出，促进仿制药质量提升。一是支持首仿品种加快注册上市。对首仿品种实施专人负责、主动对接、加强指导、全程服务，在审评审批、注册核查、产品检验等方面给予支持。二是加强委托生产监管。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504303394003434.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504303394003434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1829250122.USD","BK1593","BK4568","LU2417539215.USD","BK1515","LU2236285917.USD","LU2456880835.USD","LU2462157665.USD","LU0109394709.USD","BK4007","BK4585","02196","LU0320765992.SGD","AZN","LU0889565916.HKD","BK1191","BK4588"],"gpt_icon":0},{"id":"2531424787","title":"阿斯利康在華面臨800萬美元新罰款？公司回應了","url":"https://stock-news.laohu8.com/highlight/detail?id=2531424787","media":"21世纪经济报道","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531424787?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 09:25","pubTimestamp":1745976323,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛上海报道有最新市场消息称，4月29日，阿斯利康在最新季度的财报会议上透露，该公司可能会在中国面临一项新的罚款，金额达800万美元。意见书显示，阿斯利康涉嫌偷逃进口税款，金额达160余万美元。若阿斯利康被最终判定需承担法律责任，可能被处以未缴进口税款一至五倍的罚金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043009352594e838a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043009352594e838a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU2462157665.USD","LU2417539215.USD","BK4568","LU0109394709.USD","BK4585","LU2236285917.USD","BK4007","LU2456880835.USD","AZN","LU0320765992.SGD","BK4588","LU1829250122.USD"],"gpt_icon":0},{"id":"2531420742","title":"阿斯利康4月29日成交額為5.64億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531420742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531420742?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 09:16","pubTimestamp":1745975817,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，阿斯利康成交额为5.64亿美元，成交额较昨日增加0.18%，当日成交量为791.91万股。阿斯利康于2025年4月29日涨2.55%，报71.71美元，该股过去5个交易日涨5.66%，年初至今涨11.23%，过去60日涨2.87%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|5.64亿|0.18%|791.91万|#|2025-04-28|5.63亿|21.81%|802.34万|#|2025-04-25|4.62亿|94.02%|666.27万|#|2025-04-24|2.38亿|-38.92%|343.21万|#|2025-04-23|3.90亿|-1.09%|567.40万|1999 年，瑞典阿斯特拉公司与英国捷利康集团合并，成立了阿斯利康公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091702a46cea66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091702a46cea66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2236285917.USD","LU0320765992.SGD","LU1829250122.USD","BK4007","BK4585","AZN","LU0109394709.USD","LU2417539215.USD","LU0889565916.HKD","LU2462157665.USD","BK4588","BK4568","LU2456880835.USD"],"gpt_icon":0},{"id":"2531740951","title":"雅培4月29日成交額為5.63億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531740951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531740951?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 09:15","pubTimestamp":1745975716,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，雅培成交额为5.63亿美元，成交额较昨日增加13.22%，当日成交量为431.53万股。雅培于2025年4月29日涨0.75%，报130.5美元，该股过去5个交易日跌0.93%，年初至今涨16.51%，过去60日涨2.48%。雅培约 60% 的销售额来自美国以外地区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091531a6ce1135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091531a6ce1135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1721429741.USD","LU0868494617.USD","LU0170899867.USD","IE00BFTCPJ56.SGD","BK4504","LU1023059063.AUD","BK4592","ABT","BK4588","BK4585","LU0266013472.USD","LU2112291526.USD","LU2237957811.SGD","LU2133065610.SGD","LU2089984988.USD","LU1721429402.USD","LU1057294990.SGD","SG9999002224.SGD","IE00BJT1NW94.SGD","LU2237957902.USD","SG9999004303.SGD","LU1061106388.HKD","BK4581","LU1989763427.SGD","LU2468319806.SGD","LU1691799644.USD","BK4566","IE00B2B36J28.USD","LU1989763690.USD","BK4533","IE0002141913.USD","IE00B4R5TH58.HKD","SG9999002232.USD","BK4082","IE0009355771.USD","LU0234572021.USD","SGXZ23171101.USD","LU1914381329.SGD","LU0122379950.USD","BK4568","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2531749214","title":"【吉利德科學與美國政府達成2億美元和解協議】吉利德科學與美國政府達成2.02億美元的和解協議，以解決其向醫生支付費用併為他們提供活動餐費和差旅費以讓其開出其藥物的指控。曼哈頓聯邦檢察官指控，吉利德從2011年1月至2017年11月實施部分計劃，以推廣和增加其治療艾滋病毒的藥物的銷售量。該等活動原本純粹是為了教育目的，並提供簡單的餐點，但該公司在高檔餐廳舉辦活動。檢察官稱，許多醫生隨後開出該公司的藥物，迫使聯邦醫療保健計劃為該等處方支付數百萬美元的報銷費用。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531749214","media":"金融界","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531749214?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 09:07","pubTimestamp":1745975247,"startTime":"0","endTime":"0","summary":"吉利德科学与美国政府达成2.02亿美元的和解协议，以解决其向医生支付费用并为他们提供活动餐费和差旅费以让其开出其药物的指控。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。该等活动原本纯粹是为了教育目的，并提供简单的餐点，但该公司在高档餐厅举办活动。检察官称，许多医生随后开出该公司的药物，迫使联邦医疗保健计划为该等处方支付数百万美元的报销费用。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30090750029382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE0002270589.USD","IE00B7SZLL34.SGD","LU1839511570.USD","LU0109394709.USD","LU0889565916.HKD","IE00B19Z3581.USD","BK4550","BK4588","IE00BKVL7J92.USD","BK4566","LU0058720904.USD","LU2087621335.USD","IE00B3T34201.USD","LU1066051498.USD","GILD","BK4578","LU2468319806.SGD","LU0289739699.SGD","BK4139","LU1571399168.USD","LU1585245621.USD","LU1066053197.SGD","BK4532","LU0320765992.SGD","BK4568","IE00BZ1G4Q59.USD","LU2089984988.USD","LU0234570918.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1430594728.SGD","BK4583","BK4585"],"gpt_icon":0},{"id":"2531514749","title":"阿斯利康在中國或面臨800萬美元新罰款，涉及乳腺癌藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2531514749","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531514749?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 09:03","pubTimestamp":1745975004,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0109394709.USD","LU2417539215.USD","LU2456880835.USD","AZN","BK4588","LU1829250122.USD","LU2236285917.USD","LU2462157665.USD","BK4007","LU0320765992.SGD","BK4568","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531727623","title":"多款 FIC 生物新藥首發 AACR ！來自阿斯利康、GSK、信達...","url":"https://stock-news.laohu8.com/highlight/detail?id=2531727623","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531727623?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 08:43","pubTimestamp":1745973788,"startTime":"0","endTime":"0","summary":"2025 年 AACR 火热进行中。这次大会上，差不多有 50 款 FIC 生物新药首发亮相。据说今年这款产品就要启动首次人体临床试验了。GSK 和默克也不甘示弱，各自带来了一款 FIC 新药。信达是最多的，一口气公布了 4 款 FIC 新药，既有双抗、三抗，也有双抗 ADC和抗体类融合蛋白，药物类型特别丰富。另外，东阳光、菲鹏、辐联、启德、橙帆、塔吉瑞等十来家药企，也都在大会上展示了自家的 FIC 新药。最后，想要 2025 年 AACR 会议首发 FIC 新药清单的朋友，记得截图保存哦。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430121359a46d2035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430121359a46d2035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","LU1829250122.USD","BK4532","AZN","GSK","BK4585","GSK.UK","LU2236285917.USD","LU2462157665.USD","BK4588","LU0320765992.SGD","LU2456880835.USD","LU0889565916.HKD","LU0109394709.USD","LU2417539215.USD","BK4007"],"gpt_icon":0},{"id":"2531638715","title":"阿斯利康在中國或面臨800萬美元新罰款，涉及乳腺癌藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2531638715","media":"第一财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531638715?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 05:45","pubTimestamp":1745963100,"startTime":"0","endTime":"0","summary":"　　英国当地时间4月29日，阿斯利康在最新季度的财报会议上透露，该公司可能会在中国面临一项新的罚款，金额达800万美元。　　阿斯利康表示，最新的罚款涉嫌进口乳腺癌药物Enhertu的未缴纳税款。该公司在上一季度财报会上称，因另外两款抗癌药物Imfinzi和Imjudo未缴税款，将面临最高450万美元的罚款。去年10月底，阿斯利康前中国总裁王磊因涉嫌走私被带走。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-04-30/doc-ineuwute0399914.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-30/doc-ineuwute0399914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AZN","BK4007","BK4568","LU1829250122.USD","LU0889565916.HKD","LU2456880835.USD","LU2417539215.USD","LU2462157665.USD","LU0109394709.USD","LU0320765992.SGD","BK4585","LU2236285917.USD","BK4588"],"gpt_icon":0},{"id":"2531760523","title":"吉利德科學公司在美國就艾滋病藥物回扣問題達成和解，將支付 2.02 億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531760523","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531760523?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 02:31","pubTimestamp":1745951487,"startTime":"0","endTime":"0","summary":"更新版 1-吉利德科学公司在美国就艾滋病药物回扣问题达成和解，将支付 2.02 亿美元改写第一段；添加吉利德公司和美国律师的评论、指控、举报人详情、财务影响、署名Jonathan Stempel. 路透纽约4月29日 - 吉利德科学公司同意支付2.02亿美元，以了结一起举报人诉讼，该诉讼指控吉利德向同意开具其艾滋病药物处方的医生支付回扣，涉嫌民事欺诈。2024 年，吉利德的艾滋病药物销售总额达 196.1 亿美元，同比增长 8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R728V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1571399168.USD","LU2087621335.USD","BK4585","LU1585245621.USD","BK4578","IE00B19Z3581.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU0234570918.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","GILD","BK4532","LU2089984988.USD","LU0109394709.USD","LU0889565916.HKD","BK4139","IE00B7SZLL34.SGD","BK4583","LU1430594728.SGD","LU1066051498.USD","BK4568","LU1066053197.SGD","LU1839511570.USD","BK4588","LU0320765992.SGD","LU2468319806.SGD","IE00BKVL7J92.USD","BK4550","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2531762855","title":"阿斯利康盤中異動 下午盤股價大漲3.02%報72.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531762855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531762855?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 01:40","pubTimestamp":1745948447,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日01时40分，阿斯利康股票出现波动，股价大幅拉升3.02%。截至发稿，该股报72.05美元/股，成交量543.799万股，换手率0.18%，振幅3.30%。阿斯利康股票所在的制药行业中，整体涨幅为1.44%。该信息摘要如下：阿斯利康公布的2025年第一季度利润超出预期，并重申其全年业绩指引。财报显示，阿斯利康一季度总营收135.9亿美元，不及市场预期；核心每股收益为 2.49 美元，同比增长21%，超过分析师预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430014047a6cda7e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430014047a6cda7e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2236285917.USD","LU0320765992.SGD","LU1829250122.USD","BK4007","BK4585","AZN","LU0109394709.USD","LU2417539215.USD","LU0889565916.HKD","LU2462157665.USD","BK4588","BK4568","LU2456880835.USD"],"gpt_icon":0},{"id":"2531764411","title":"吉利德科學公司就醫生回扣問題與美國達成 2.02 億美元和解協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2531764411","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531764411?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 01:39","pubTimestamp":1745948380,"startTime":"0","endTime":"0","summary":"吉利德科学公司就医生回扣问题与美国达成 2.02 亿美元和解协议路透纽约4月29日 - 美国曼哈顿检察官办公室周二表示，吉利德科学公司GILD.O已达成一项2.02亿美元的和解协议，以解决一起指控该公司向同意处方其艾滋病药物的医生支付回扣的民事欺诈诉讼。该和解协议解决了吉利德公司向参加吉利德公司演讲活动的医生支付酬金、餐费和差旅费，以诱使他们开具几种艾滋病药物处方的指控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R7264:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU1430594728.SGD","IE00B19Z3581.USD","BK4532","LU1066051498.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","BK4566","BK4550","IE0002270589.USD","LU0058720904.USD","LU2468319806.SGD","BK4585","BK4139","BK4568","LU0109394709.USD","LU1839511570.USD","LU2087621335.USD","LU1585245621.USD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4578","LU1066053197.SGD","GILD","LU0234570918.USD","BK4583","BK4588","IE00BSNM7G36.USD","LU0320765992.SGD","IE00BKVL7J92.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":193,"code":"91000000","status":"200"}]}}